Investigational drugs for immune thrombocytopenia
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2022.2075340
Abstract: ABSTRACT Introduction Primary immune thrombocytopenia (ITP) is an acquired autoimmune disease of unknown cause. Autoantibodies, self-reactive T cells and other immune abnormalities, with impairment of platelet production, lead to a reduced platelet count. Until recently,… read more here.
Keywords: drugs immune; receptor; investigational drugs; immune thrombocytopenia ... See more keywords
Epigenetic Drugs and Their Immune Modulating Potential in Cancers
Sign Up to like & getrecommendations! Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10020211
Abstract: Epigenetic drugs are used for the clinical treatment of hematologic malignancies; however, their therapeutic potential in solid tumors is still under investigation. Current evidence suggests that epigenetic drugs may lead to antitumor immunity by increasing… read more here.
Keywords: immune modulating; drugs immune; epigenetic drugs; potential cancers ... See more keywords